TGFB2-AS1 inhibits triple-negative breast cancer progression via interaction with SMARCA4 and regulating its targets TGFB2 and SOX2

Triple-negative breast cancer (TNBC) is the most challenging breast cancer subtype for its high rates of relapse, great metastatic potential, and short overall survival. How cancer cells acquire metastatic potency through the conversion of noncancer stem-like cells into cancer cells with stem-cell p...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhou, Cixiang, Wang, Difei, Li, Jingchi, Wang, Qiuyu, Wo, Lulu, Zhang, Xin, Hu, Zhexuan, Wang, Zheng, Zhan, Mengna, He, Ming, Hu, Guohong, Chen, Xiaosong, Shen, Kunwei, Chen, Guo-Qiang, Zhao, Qian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: National Academy of Sciences 2022
Materias:
Biological Sciences
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9522332/
https://www.ncbi.nlm.nih.gov/pubmed/36126099
http://dx.doi.org/10.1073/pnas.2117988119

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9522332/
https://www.ncbi.nlm.nih.gov/pubmed/36126099
http://dx.doi.org/10.1073/pnas.2117988119

Ejemplares similares